De Olivera and colleagues found that combination of dacarbazine (DTIC) and WEB 2170 (PAFR antagonist) significantly improves survival of B16F10 melanoma-bearing mice compared to either agent used alone (146). The gene discussed is PTAFR; the disease is melanoma.